Howard Lee
Affiliations: | Seoul National University Hospital | Seoul National University College of Medicine, Seoul, Seoul, South Korea |
Google:
"Howard Lee"Mean distance: (not calculated yet)
Collaborators
Sign in to add collaborator
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kim A, Dueker SR, Hwang JG, et al. (2020) An Investigation of the Metabolism and Excretion of KD101 and Its Interindividual Differences: A Microtracing Mass Balance Study in Humans. Clinical and Translational Science |
| Kim S, Kim S, Lee H. (2020) A critical review of the United States regulatory pathways for determining the equivalence of efficacy between CT-P13 and original infliximab (Remicade). Drug Design, Development and Therapy. 14: 2831-2840 |
| Lee JH, Faderl S, Pagel JM, et al. (2020) Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome. Blood Advances. 4: 2032-2043 |
| Lee SW, Choi D, Heo M, et al. (2020) hIL-7-hyFc, a long-acting IL-7, increased absolute lymphocyte count in healthy subjects. Clinical and Translational Science |
| Kim A, Dueker SR, Dong F, et al. (2020) Human ADME for YH12852 using wavelength scanning cavity ring-down spectroscopy (WS-CRDS) after a low radioactivity dose. Bioanalysis. 12: 87-98 |
| Huh KY, Shin W, Baek E, et al. (2020) 948-P: A Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136, a Novel Long-Acting Glucagon Analogue, in Healthy Subjects Diabetes. 69 |
| Lee HA, Yu KS, Park SI, et al. (2019) URC102, a potent and selective inhibitor of hURAT1, reduced serum uric acid in healthy volunteers. Rheumatology (Oxford, England) |
| Kim Y, Hatley O, Rhee SJ, et al. (2019) Development of a Korean-specific virtual population for physiologically-based pharmacokinetic modeling and simulation. Biopharmaceutics & Drug Disposition |
| Lee HA, Lee KR, Jang SB, et al. (2019) A physiologically-based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel K-competitive acid blocker. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences |
| Polasek TM, Rostami-Hodjegan A, Yim DS, et al. (2019) What Does it Take to Make Model-Informed Precision Dosing Common Practice? Report from the 1st Asian Symposium on Precision Dosing. The Aaps Journal. 21: 17 |